| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $26.89B | $25.92B | $25.49B |
| YoY Revenue Growth % | +3.7% | +1.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $12.39B | $11.71B | $11.65B |
| Operating Margin % | 46.1% | 45.2% | 45.7% |
| Net Income (GAAP) | $8.56B | $8.22B | $8.47B |
| EBITDA (Normalized) | $15.09B | $13.93B | $12.56B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $10.55B | $9.45B | $9.61B |
| Capital Expenditures (CapEx) | $3.37B | $2.77B | $1.15B |
| Free Cash Flow (FCF) | $7.19B | $6.67B | $8.46B |
| FCF Margin % | 26.7% | 25.7% | 33.2% |
| Return on Invested Capital (ROIC %) | 26.2% | 27.6% | 15.2% |
| Cash & Short-Term Equivalents | $774.0M | $1.08B | — |
| Total Debt (Short + Long Term) | $39.97B | $38.42B | $23.44B |
| Total Stockholders' Equity | -$1.79B | -$3.80B | $48.08B |